Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD

The Impact of Baseline Visual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical Setting

NCT03278262 ·Status: COMPLETED

A Study to Learn How Well Aflibercept Injected Into the Eye Works and How Safe it is When Given in Customized Treatment Intervals in Patients With an Eye Disease Called Neovascular Age-related Macular Degeneration After Start of Treatment

NCT05473715 ·Status: TERMINATED ·Phase: PHASE4

Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical Practice

NCT03290794 ·Status: COMPLETED

Study for Collection of Aflibercept Data in Routine Practice

NCT02811692 ·Status: COMPLETED

Aflibercept Injection Into the Vitreous Body of the Eye: Study to Learn More About Patient Relevant Outcomes, Real World Treatment Patterns and How Well the Treatment Works for Patients Suffering From Abnormal Growth of New Blood Vessels Under the Retina.

NCT03714308 ·Status: COMPLETED

Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

NCT02540954 ·Status: COMPLETED ·Phase: PHASE3

Evaluate the Effectiveness of Intravitreal (IVT) Aflibercept Injection in Clinical Practice in naïve Patients With Neovascular Age-related Macular Degeneration (nAMD)

NCT03411941 ·Status: COMPLETED

Assessment of Proactive Treatments in Patients With Wet Age-related Macular Degeneration (wAMD) Which Have Never Undergone Treatment of This Particular Disease

NCT03939767 ·Status: COMPLETED

Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration

NCT02157077 ·Status: COMPLETED ·Phase: PHASE3

Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in Japan

NCT02541084 ·Status: COMPLETED

Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration

NCT01914380 ·Status: COMPLETED

To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.

NCT02540369 ·Status: COMPLETED

Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration

NCT02305238 ·Status: COMPLETED ·Phase: PHASE4

Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)

NCT00964795 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor

NCT01896284 ·Status: COMPLETED ·Phase: PHASE4

A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics

NCT02005133 ·Status: TERMINATED

Analysis of naïve Patients With Age-related Macular Degeneration of the Neovascular Type and Treated With Aflibercept (Eylea®) in "Treat-and-extend" at CHU Brugmann

NCT04891835 ·Status: COMPLETED

Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)

NCT02818998 ·Status: COMPLETED ·Phase: PHASE3

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)

NCT00637377 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept

NCT02615496 ·Status: COMPLETED

Aflibercept (Eylea) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy

NCT02289924 ·Status: COMPLETED

Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

NCT04423718 ·Status: COMPLETED ·Phase: PHASE3

Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)

NCT00509795 ·Status: COMPLETED ·Phase: PHASE3

Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration

NCT07235527 ·Status: RECRUITING

Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

NCT04126317 ·Status: COMPLETED ·Phase: PHASE2